Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services When will the FDA reclassify BPC 157 to Category 1 Octagon AI The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA mulls compounding for peptides previously flagged over safety risks BioSpace